Accessibility and affordability of emollients in the management of atopic dermatitis in Africa
Journal of Investigative Dermatology · 2026-03
DOI: 10.1016/j.jid.2026.02.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-03. Verfasst von Erere Otrofanowei und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos/Lagos University Teaching Hospital, Lagos, Nigeria. El…. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a prevalent chronic inflammatory skin condition affecting up to 20% of children and 10% of adults in Africa. The management of AD relies heavily on the use of emollients, which form the foundation of treatment by enhancing the skin barrier and preventing the condition's flare-ups. However, access to emollients remains a significant challenge across Africa, impeding effective treatment and worsening the quality of life in those affected. The research utilized a cross-sectional survey conducted between October 2023 and April 2024, gathering data from dermatologists in 16 African countries. Information was collected regarding the availability of traditional and industrial emollients, costs, economic conditions, and healthcare infrastructure. Results indicate that traditional emollients such as coconut oil and shea butter are widely available, though their quality and consistency vary. Imported emollients, including Vaseline® Petroleum Jelly and products from brands such as Dexeryl, Topicrem®, and CeraVe®, are more commonly prescribed. However, the cost of these imported products is a significant barrier. In conclusion, this study highlights significant disparities and major economic barriers to accessing emollient treatments for AD in SSA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos/Lagos University Teaching Hospital, Lagos, Nigeria. Electronic address: eotrofanowei@unilag.edu.ng.
- Université Félix Houphouët- Boigny, Centre Hospitalier Universitaire de Treichville, Abidjan, Cote d'Ivoire.
- Faculty of Health Sciences, University of Abomey-Calavi, Cotonou, Benin.
- Department of Dermatology, Hedi Chaker Hospital, University of Sfax, Sfax, Tunisia.
- Department of Medicine, Lagos State University Teaching Hospital, Lagos, Nigeria.
- Department of Dermatology, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Zitieren
APA
Otrofanowei, E., Ahogo, C. K., Atadokpede, F., Bahloul, E., Cole-Adeife, O., Dlova, N., Doni, S. N., Faye, O., Ibekwe, P. U., Kayitenkore, K., Kebe, M., Kombo Bayonne, E. S., Kouotou, E. A., Ly, F., Mavura, D., Nkosiyenzile, C., Ouédraogo, A. N., Rakotonandrasana, F., Fandresena, S., …, & Rapelanoro Rabenja, F. (2026). Accessibility and affordability of emollients in the management of atopic dermatitis in Africa. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2026.02.013
Vancouver
Otrofanowei E, Ahogo CK, Atadokpede F, Bahloul E, Cole-Adeife O, Dlova N, et al. Accessibility and affordability of emollients in the management of atopic dermatitis in Africa. Journal of Investigative Dermatology. 2026. doi:10.1016/j.jid.2026.02.013
BibTeX
@article{Otrofanowei2026,
author = {Otrofanowei, Erere and Ahogo, Celestin Kouadio and Atadokpede, Felix and Bahloul, Emna and Cole-Adeife, Olufolakemi and Dlova, Ncoza and Doni, Shimelis Nigusse and Faye, Ousmane and Ibekwe, Perpetua U and Kayitenkore, Kayitesi and Kebe, Mariem and Kombo Bayonne, Edith Sophie and Kouotou, Emmanuel Armand and Ly, Fatimata and Mavura, Daudi and Nkosiyenzile, Cele and Ouédraogo, Amina Nomtondo and Rakotonandrasana, Fenohasina and Fandresena, Sendrasoa and Seudjip Nono, Lydie Joelle and Turki, Hamid and Ogu, Chimsom and Rapelanoro Rabenja, Fahafahantsoa},
title = {Accessibility and affordability of emollients in the management of atopic dermatitis in Africa},
journal = {Journal of Investigative Dermatology},
year = {2026},
doi = {10.1016/j.jid.2026.02.013}
}
EUVIMED